• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者的性别差异:关注严重程度和死亡率。

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.

机构信息

Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Department of Internal Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.

DOI:10.3389/fpubh.2020.00152
PMID:32411652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7201103/
Abstract

The recent outbreak of Novel Coronavirus Disease (COVID-19) is reminiscent of the SARS outbreak in 2003. We aim to compare the severity and mortality between male and female patients with COVID-19 or SARS. We extracted the data from: (1) a case series of 43 hospitalized patients we treated, (2) a public data set of the first 37 cases of patients who died of COVID-19 and 1,019 patients who survived in China, and (3) data of 524 patients with SARS, including 139 deaths, from Beijing in early 2003. Older age and a high number of comorbidities were associated with higher severity and mortality in patients with both COVID-19 and SARS. Age was comparable between men and women in all data sets. In the case series, however, men's cases tended to be more serious than women's ( = 0.035). In the public data set, the number of men who died from COVID-19 is 2.4 times that of women (70.3 vs. 29.7%, = 0.016). In SARS patients, the gender role in mortality was also observed. The percentage of males were higher in the deceased group than in the survived group ( = 0.015). While men and women have the same prevalence, men with COVID-19 are more at risk for worse outcomes and death, independent of age.

摘要

新型冠状病毒病(COVID-19)的最近爆发让人想起 2003 年的 SARS 爆发。我们旨在比较 COVID-19 或 SARS 患者中男性和女性的严重程度和死亡率。我们从以下方面提取数据:(1)我们治疗的 43 例住院患者的病例系列,(2)中国首例死于 COVID-19 的 37 例患者和 1019 例存活患者的公共数据集,以及(3)2003 年初北京的 524 例 SARS 患者的数据,包括 139 例死亡。在 COVID-19 和 SARS 患者中,年龄较大和合并症较多与严重程度和死亡率较高相关。在所有数据集中,男性和女性的年龄相当。然而,在病例系列中,男性的病例往往比女性严重( = 0.035)。在公共数据集中,死于 COVID-19 的男性人数是女性的 2.4 倍(70.3%对 29.7%, = 0.016)。在 SARS 患者中,也观察到了死亡率的性别作用。死亡组中男性的比例高于存活组( = 0.015)。虽然男性和女性的患病率相同,但 COVID-19 男性的预后和死亡风险更高,独立于年龄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/e192e67da982/fpubh-08-00152-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/b250a6a0e51a/fpubh-08-00152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/c9de0a6866ba/fpubh-08-00152-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/e192e67da982/fpubh-08-00152-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/b250a6a0e51a/fpubh-08-00152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/c9de0a6866ba/fpubh-08-00152-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/751a/7201103/e192e67da982/fpubh-08-00152-g0003.jpg

相似文献

1
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.COVID-19 患者的性别差异:关注严重程度和死亡率。
Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.
2
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.美国 10131 名 SARS-CoV-2 感染退伍军人住院、机械通气或死亡的危险因素。
JAMA Netw Open. 2020 Sep 1;3(9):e2022310. doi: 10.1001/jamanetworkopen.2020.22310.
3
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
4
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
5
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
6
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病:一项快速综述
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013574. doi: 10.1002/14651858.CD013574.pub2.
7
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study.Covid-19 和性别:女性重症疾病的发病率较低,但死亡率相同——一项观察性研究。
BMC Pulm Med. 2021 Mar 20;21(1):96. doi: 10.1186/s12890-021-01455-0.
8
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.中国全国范围内的分析:湖北省(疫情中心)和湖北省外(非疫情中心)住院治疗的 COVID-19 患者的临床特征和结局。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00562-2020. Print 2020 Jun.
9
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
10
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.

引用本文的文献

1
Tenofovir attenuates cytokine storm and bronchiolar damage in a mouse model of bleomycin-induced acute lung injury.替诺福韦减轻博来霉素诱导的急性肺损伤小鼠模型中的细胞因子风暴和细支气管损伤。
Sci Rep. 2025 Aug 27;15(1):31570. doi: 10.1038/s41598-025-16560-x.
2
COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.2020 - 2023年维多利亚市新冠病毒病疫苗接种状况及与该病死亡相关的因素:横断面研究
Epidemiol Serv Saude. 2025 Aug 8;34:e20240700. doi: 10.1590/S2237-96222025v34e20240700.en. eCollection 2025.
3
Comparative Effectiveness of Remdesivir in Hospitalized COVID-19 Patients: A Retrospective Cohort Study From the Pre-vaccination and Omicron Eras.

本文引用的文献

1
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
2
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
3
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
瑞德西韦对住院COVID-19患者的疗效比较:一项来自疫苗接种前和奥密克戎时代的回顾性队列研究。
Cureus. 2025 Jul 8;17(7):e87561. doi: 10.7759/cureus.87561. eCollection 2025 Jul.
4
Sex differences in inflammation and markers of gut integrity in long COVID.长期新冠患者炎症及肠道完整性标志物的性别差异
Sci Rep. 2025 Jul 28;15(1):27374. doi: 10.1038/s41598-025-11470-4.
5
Incidence of Neurological Manifestations in Critically Ill COVID-19 Patients: A Low-Resource Setting Experience.重症 COVID-19 患者神经系统表现的发生率:低资源环境下的经验
Cureus. 2025 Jun 9;17(6):e85616. doi: 10.7759/cureus.85616. eCollection 2025 Jun.
6
Epidemiological profiles and outcomes of healthcare workers hospitalized for COVID-19 in five Sub-Saharan African countries: a cohort study.撒哈拉以南非洲五个国家中因新冠肺炎住院的医护人员的流行病学概况及结局:一项队列研究
F1000Res. 2024 Jun 18;13:655. doi: 10.12688/f1000research.150775.1. eCollection 2024.
7
The Risk of Arrhythmias in Patients with COVID-19.新型冠状病毒肺炎患者发生心律失常的风险
Biomedicines. 2025 Jun 3;13(6):1368. doi: 10.3390/biomedicines13061368.
8
Sex Bias in Systemic Sclerosis: from Clinical to Immunological Differences.系统性硬化症中的性别偏见:从临床差异到免疫差异
Clin Rev Allergy Immunol. 2025 May 27;68(1):51. doi: 10.1007/s12016-025-09062-1.
9
Long COVID and endometriosis: a systematic review and meta-analysis.长新冠与子宫内膜异位症:一项系统评价与荟萃分析。
BMC Womens Health. 2025 May 15;25(1):229. doi: 10.1186/s12905-025-03761-9.
10
Limitations of the Male/Female Binary for Studying the Influences of Sex- and Gender-Related Factors on Health.研究性别相关因素对健康影响时男性/女性二元划分的局限性。
Am J Hum Biol. 2025 May;37(5):e70064. doi: 10.1002/ajhb.70064.
中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例,提示存在人际传播:一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
7
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
8
Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?心血管疾病的新兴标志物:血管紧张素转换酶 2 在哪里适应?
Clin Exp Pharmacol Physiol. 2013 Aug;40(8):551-9. doi: 10.1111/1440-1681.12069.
9
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.从沙特阿拉伯一名患有肺炎的男子中分离出一种新型冠状病毒。
N Engl J Med. 2012 Nov 8;367(19):1814-20. doi: 10.1056/NEJMoa1211721. Epub 2012 Oct 17.
10
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.严重急性呼吸综合征冠状病毒与其受体结合会损伤胰岛细胞,导致急性糖尿病。
Acta Diabetol. 2010 Sep;47(3):193-9. doi: 10.1007/s00592-009-0109-4. Epub 2009 Mar 31.